Difficulties of anemia diagnosis in patients with B-cell chronic lymphocytic leukemia
暂无分享,去创建一个
[1] S. Malek,et al. Chronic Lymphocytic Leukemia , 2019, Methods in Molecular Biology.
[2] R. Means. Pure red cell aplasia. , 2016, Blood.
[3] R. Means. Pure red cell aplasia. , 2016, Hematology. American Society of Hematology. Education Program.
[4] K. Rogers,et al. Secondary autoimmune cytopenias in chronic lymphocytic leukemia. , 2016, Seminars in oncology.
[5] A. Neri,et al. Autoimmune cytopenias in chronic lymphocytic leukemia , 2014, American journal of hematology.
[6] Ирина Николаевна Лаврентьева,et al. ПАРВОВИРУС В19 ЧЕЛОВЕКА: ХАРАКТЕРИСТИКА ВОЗБУДИТЕЛЯ, РАСПРОСТРАНЕНИЕ И ДИАГНОСТИКА ОБУСЛОВЛЕННОЙ ИМ ИНФЕКЦИИ , 2014 .
[7] F. caligaris-Cappio,et al. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy? , 2011, Current opinion in oncology.
[8] E. Montserrat,et al. Chronic lymphocytic leukemia and autoimmunity: a systematic review , 2011, Haematologica.
[9] E. Montserrat,et al. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. , 2010, Blood.
[10] A. Berrebi,et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial , 2010, The Lancet.
[11] P. Truong,et al. Population-Based Analysis of the Frequency of Anemia and its Management Before and During Chemotherapy in Patients With Malignant Lymphoma , 2010, American journal of clinical oncology.
[12] P. Ganly,et al. Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Hirokawa,et al. Acquired pure red cell aplasia: updated review of treatment , 2008, British journal of haematology.
[14] S. Amadori,et al. Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. , 2007, Blood.
[15] P. Rodon,et al. Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath‐1H , 2003, European journal of haematology.
[16] A. Zanella,et al. In vitro production of anti‐RBC antibodies and cytokines in chronic lymphocytic leukemia , 2002, American journal of hematology.
[17] T. Kipps,et al. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. , 1993, Blood.